Table S1. Codes Used to Identify CKD, Anemia, Treatment, and Comorbid Conditions. (PDF 35 kb
Additional file 1: Table S1. Adjusted and unadjusted models for logistic regressions between race an...
Pilot clinical trials in chronic kidney disease patients on hemodialysis. The sample of pilot clinic...
Summary of study designs and primary outcomes of interest. Provides an overview of the study designs...
Table S4. Anemia Treatment in Stage 3â5 NDD-CKD Patients with Anemia by Stage, 20% Medicare and Co...
Figure S1. Flowchart for patient selection. CKD, chronic kidney disease; ESRD, end-stage renal disea...
Table S2. Baseline Characteristics and Comorbid Conditions in Stage 3â5 NDD-CKD Patients, 20% Medi...
Table S1. Definitions for Comorbid Health Conditions. Provides the diagnostic codes used to define t...
Appendix Table S1. Diagnosis Codes for Selected Comorbid Conditions. ICD9 codes used to identify pro...
Table S1. Longitudinal laboratory measurements and ESA doses for baseline ESA users and ESA Naives. ...
Anticipated and actual target distributions of CKD etiology and renal function, C-STRIDE study (Nov ...
Table S1. One-way ANOVA comparing the various Biochemical parameters in patients stratified for ESRD...
Appendix Table S2. Characteristics of primary care patients with CKD based on eGFR (n =â1767). Pa...
Table S1. ICD 9 codes for disease conditions in the study. Table S2. Medications used to treat chron...
Compliance of different guidelines with AGREE-II. Description of how the included guidelines conform...
Table S1. Stage 5D Classification criteria in PHS CKD Registry. Variables considered by algorithm fo...
Additional file 1: Table S1. Adjusted and unadjusted models for logistic regressions between race an...
Pilot clinical trials in chronic kidney disease patients on hemodialysis. The sample of pilot clinic...
Summary of study designs and primary outcomes of interest. Provides an overview of the study designs...
Table S4. Anemia Treatment in Stage 3â5 NDD-CKD Patients with Anemia by Stage, 20% Medicare and Co...
Figure S1. Flowchart for patient selection. CKD, chronic kidney disease; ESRD, end-stage renal disea...
Table S2. Baseline Characteristics and Comorbid Conditions in Stage 3â5 NDD-CKD Patients, 20% Medi...
Table S1. Definitions for Comorbid Health Conditions. Provides the diagnostic codes used to define t...
Appendix Table S1. Diagnosis Codes for Selected Comorbid Conditions. ICD9 codes used to identify pro...
Table S1. Longitudinal laboratory measurements and ESA doses for baseline ESA users and ESA Naives. ...
Anticipated and actual target distributions of CKD etiology and renal function, C-STRIDE study (Nov ...
Table S1. One-way ANOVA comparing the various Biochemical parameters in patients stratified for ESRD...
Appendix Table S2. Characteristics of primary care patients with CKD based on eGFR (n =â1767). Pa...
Table S1. ICD 9 codes for disease conditions in the study. Table S2. Medications used to treat chron...
Compliance of different guidelines with AGREE-II. Description of how the included guidelines conform...
Table S1. Stage 5D Classification criteria in PHS CKD Registry. Variables considered by algorithm fo...
Additional file 1: Table S1. Adjusted and unadjusted models for logistic regressions between race an...
Pilot clinical trials in chronic kidney disease patients on hemodialysis. The sample of pilot clinic...
Summary of study designs and primary outcomes of interest. Provides an overview of the study designs...